A Kibel, AM Lukinac, V Dambic, I Juric… - Oxidative medicine …, 2020 - Wiley Online Library
One of the novel interesting topics in the study of cardiovascular disease is the role of the oxidation system, since inflammation and oxidative stress are known to lead to …
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
AML Seca, DCGA Pinto - Marine drugs, 2018 - mdpi.com
Hypertension and obesity are two significant factors that contribute to the onset and exacerbation of a cascade of mechanisms including activation of the sympathetic and renin …
E Belaidi, J Morand, E Gras, JL Pépin… - Pharmacology & …, 2016 - Elsevier
Obstructive sleep apnea (OSA) is now recognized as an independent and important risk factor for cardiovascular diseases such as hypertension, coronary heart disease, heart …
The developmental origins of health and disease theory is based on evidence that a suboptimal environment during fetal and neonatal development can significantly impact the …
NM Rogers, M Sharifi-Sanjani, M Yao… - Cardiovascular …, 2017 - academic.oup.com
Aims Thrombospondin-1 (TSP1) is a ligand for CD47 and TSP1−/− mice are protected from pulmonary hypertension (PH). We hypothesized the TSP1–CD47 axis is upregulated in …
Cardiovascular diseases (CVD) constitute the major cause of death worldwide and show a higher prevalence in the adult population. The human umbilical cord consistsof two arteries …
N Maleki, RK Ravesh, S Salehiyeh, AF Faiz… - Gene, 2022 - Elsevier
Background Silibinin is a polyphenolic compound that could modulate estrogen receptor activation. Vascular dysfunction is considered a key initiator in atherosclerosis and may …
AF Ceylan, S Wang, MR Kandadi, J Chen… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Abstract Endothelin (ET)-1 is implicated in the pathophysiology of cardiovascular diseases although its role in obesity anomalies has not been fully elucidated. This study was …